UBS: Eli Lilly's 'Outlook Continuing To Improve'
February 02, 2015 at 10:25 AM EST
UBS on Monday issued a report on Eli Lilly and Co (NYSE: LLY). The firm rates Eli Lilly as Neutral with a one-year price target of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.